Combination of oral, gene therapies may be best path for geographic atrophy

NEW YORK — In this video, David Eichenbaum, MD, director of research at Retina Vitreous Associates of Florida, discussed the outlook for oral therapies in the treatment of geographic atrophy at OSN New York Retina.

Eichenbaum said that oral therapies might provide an easier experience for patients over gene therapies and could ideally work in concert with other therapy programs.

“The ultimate path to treatment may actually include a combination of these therapies inhibiting complement in multiple different ways,” Eichenbaum said.

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

” data-action=subscribe>
Subscribe

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Expert Perspectives in Geographic Atrophy